Potential Impact of Using Canadian Syncope Risk Score onEmergency Department Hospitalizations for Syncope
Western Journal of Emergency Medicine · 2025
DOI: 10.5811/westjem.42019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Western Journal of Emergency Medicine, 2025. Verfasst von Andrea W Harris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Hospital, Department of Emergency Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Syncope, Emergency Service, Hospital, Hospitalization. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Introduction
Syncope is a common emergency department (ED) presentation and frequently results in low-yield hospitalizations. The Canadian Syncope Risk Score (CSRS) is a validated risk stratification score that identifies 30-day risk of serious adverse events for patients presenting with syncope. In this retrospective, cross-sectional study we aimed to evaluate syncope admissions with the CSRS to determine potentially unnecessary hospitalizations.
Methods
We identified patient visits for syncope at 11 EDs from February 2019–January 2020. We excluded patients with additional serious diagnoses that would have independently required admission and those who were discharged. We then randomly sampled the remaining charts until finding 200 that met study inclusion criteria on full chart review. We retrospectively calculated CSRS via manual chart review and identified the proportion of patients with low-risk CSRS. We compared demographic characteristics between those with low- vs medium- and high-risk CSRS.
Results
We identified 5,718 adult patients hospitalized for syncope. Of these patient visits 3,999 were initially excluded, 336 were sampled, and 200 included for analysis. Of these, 39% (77/200, 95% CI 32-46%]) were low risk (CSRS < 1). Patients with low-risk CSRSs were younger (61.2 years vs 70.6 years of age; absolute difference [AD] 9.4 years; 95% CI 4.8-13.9), less likely to have heart disease (1.3% vs 61.8%; AD 60.5%, 95% CI -69.4% to -51.5%), and more likely to have substance use disorder (14.3% vs 4.9%; AD 9.4%, 95% CI 0.7-18.1%).
Conclusion
In this sample of patients hospitalized for syncope, 39% had low-risk Canadian Syncope Risk Score. Had the CSRS been used, these patients could have been safely discharged, as their estimated 30-day serious adverse event rate was < 1%. Wider adoption of the CSRS could potentially reduce unnecessary hospitalizations for patients with syncope.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Johns Hopkins Hospital, Department of Emergency Medicine, Baltimore, Maryland.
- University of Maryland School of Medicine, Baltimore, Maryland.
- University of Maryland School of Medicine, Department of Emergency Medicine, Baltimore, Maryland.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Harris, A. W., LaBonte, L., Massaccesi, G., Stryckman, B., Myers, B. A., Gingold, D. B., & Wilkerson, R. G. (2025). Potential Impact of Using Canadian Syncope Risk Score onEmergency Department Hospitalizations for Syncope. Western Journal of Emergency Medicine. https://doi.org/10.5811/westjem.42019
Vancouver
Harris AW, LaBonte L, Massaccesi G, Stryckman B, Myers BA, Gingold DB, et al. Potential Impact of Using Canadian Syncope Risk Score onEmergency Department Hospitalizations for Syncope. Western Journal of Emergency Medicine. 2025. doi:10.5811/westjem.42019
BibTeX
@article{Harris2025,
author = {Harris, Andrea W and LaBonte, Lindsie and Massaccesi, Guido and Stryckman, Benoit and Myers, Bennett A and Gingold, Daniel B and Wilkerson, R Gentry},
title = {Potential Impact of Using Canadian Syncope Risk Score onEmergency Department Hospitalizations for Syncope},
journal = {Western Journal of Emergency Medicine},
year = {2025},
doi = {10.5811/westjem.42019}
}
EUVIMED